We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patient Groups Challenge CVS Plan to Deny Coverage Based on ICER Cost-Effectiveness
Patient Groups Challenge CVS Plan to Deny Coverage Based on ICER Cost-Effectiveness
Dozens of patient groups penned a letter to CVS Health’s President and CEO Larry Merlo urging the company to scrap its recently announced plan to deny coverage of drugs that fail to meet a certain level of cost-effectiveness.